SRK-015
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Spinal Muscular Atrophy
Conditions
Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA, Neuromuscular Diseases, Muscular Atrophy, Atrophy, Muscular Atrophy, Spinal, Neuromuscular Manifestations
Trial Timeline
Apr 22, 2019 → Feb 28, 2024
NCT ID
NCT03921528About SRK-015
SRK-015 is a phase 2 stage product being developed by Scholar Rock Holding for Spinal Muscular Atrophy. The current trial status is completed. This product is registered under clinical trial identifier NCT03921528. Target conditions include Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03921528 | Phase 2 | Completed |
Competing Products
20 competing products in Spinal Muscular Atrophy